Great by Choice

Jim Collins and Morten T. Hansen, both management researchers, spent nine years investigating a central question: Why do some companies thrive in uncertainty, chaos, and instability while others do not? Their comparative historical study began in 2002, prompted by the September 11 attacks, the collapse of the bull market, and a growing sense of vulnerability in an increasingly disordered world.

The authors screen 20,400 companies through 11 layers of selection criteria to identify what they call "10X" cases: companies that beat their industry indexes by at least 10 times over eras of 15 or more years, achieved those results in turbulent environments, and began from positions of vulnerability as young or small enterprises. The final seven 10X cases are Amgen (biotechnology), Biomet (medical devices), Intel (semiconductors), Microsoft (software), Progressive Insurance, Southwest Airlines, and Stryker (surgical devices). Each is matched with a comparison company in the same industry that had similar opportunities but did not achieve great performance: Genentech, Kirschner, AMD, Apple, Safeco, Pacific Southwest Airlines (PSA), and United States Surgical Corporation (USSC), respectively. The authors collect more than 7,000 historical documents and emphasize that they study historical dynastic eras ending in 2002, not the companies as they exist today.

To frame their findings, the authors open with an extended analogy comparing two explorers who raced to reach the South Pole in 1911. Norwegian explorer Roald Amundsen spent years preparing with extreme rigor, apprenticing with Indigenous Arctic peoples, testing food supplies, and building enormous logistical buffers. British explorer Robert Falcon Scott prepared far less intensively, chose ponies over dogs, relied on untested motor sledges, and left dangerously thin supply margins. Both faced identical environmental conditions, yet Amundsen reached the Pole first and returned safely, while Scott arrived 34 days later and died with his entire team. The authors argue that 10X business leaders behaved like Amundsen, while comparison leaders behaved more like Scott.

The book identifies three core behavioral traits that distinguish 10X leaders. The first is fanatic discipline: extreme consistency of action aligned with values, goals, and performance standards. Peter Lewis of Progressive Insurance exemplified this by making Progressive the first SEC-listed company to publish monthly financial statements rather than play Wall Street's earnings-guidance game. The second trait is empirical creativity, a reliance on direct observation and experimentation rather than opinion or conventional wisdom. Intel cofounder Andy Grove, upon receiving a prostate cancer diagnosis, immersed himself in primary medical research and constructed his own decision trees before choosing a treatment that contradicted the dominant recommendation. The third trait is productive paranoia, a state of hypervigilance channeled into preparation and large margins of safety. Bill Gates wrote a "nightmare memo" listing competitive threats even as Microsoft dominated its industry and insisted the company maintain enough cash to operate for a full year without revenue. Underlying all three behaviors is Level 5 ambition: passion directed toward a cause larger than oneself, exemplified by Biomet CEO Dane Miller, who held zero stock options while ensuring his employees had them.

The authors then present four operational concepts that translate these traits into practice. The first is the 20 Mile March, a commitment to hitting concrete performance markers with great consistency regardless of conditions, paired with the discipline to restrain growth in good times. Under CEO John Brown, Stryker set a benchmark of 20 percent net income growth every year as "the law" (42), hitting the target more than 90 percent of the time. Southwest Airlines maintained 30 consecutive years of profitability even when the airline industry lost $13 billion in the early 1990s, while simultaneously limiting expansion to only four new cities in 1996 when more than 100 clamored for service. Comparison companies repeatedly failed to march: Safeco abandoned its underwriting discipline and made a massive acquisition that led to five consecutive unprofitable years, and AMD tripled its long-term debt while chasing rapid growth before the semiconductor industry collapsed in 1985.

The second concept is "fire bullets, then cannonballs," describing a pattern of conducting low-cost, low-risk experiments (bullets) to gain empirical validation before concentrating resources into large commitments (cannonballs). The authors find that in only three of seven pairs was the 10X case more innovative than its comparison. Genentech outpaced Amgen by more than two times in patent productivity, yet Amgen's financial performance exceeded Genentech's by a factor of more than 30 to one. Amgen fired dozens of experimental bullets, from leukocyte interferon to bioengineered indigo for blue jeans, before concentrating on erythropoietin (EPO), a protein that stimulates red-blood-cell production, once it showed clear empirical promise. Across all companies, calibrated cannonballs had an 88 percent success rate versus 23 percent for uncalibrated ones.

The third concept involves managing risk through productive paranoia. The authors frame this through the 1996 Mount Everest disaster: filmmaker David Breashears chose to descend despite clear weather because he had brought enough oxygen and supplies for multiple summit attempts, while guides who continued upward carried supplies for only one bid and died in the subsequent storm. The 10X companies carried 3 to 10 times the ratio of cash to assets compared to the broader market, and this prudence was already in place during the first five years after each company's initial public offering. Southwest Airlines maintained $1 billion in cash before September 11, 2001, enabling it to continue full operations and turn a profit in both 2001 and 2002. In a systematic analysis of 114 decisions, only 10 percent of 10X decisions involved Death Line risk, meaning risk that could threaten the enterprise's survival, versus 36 percent for comparisons.

The fourth concept is the SMaC recipe (Specific, Methodical, and Consistent), a set of durable operating practices creating a replicable success formula. Howard Putnam's 10-point recipe for Southwest Airlines, articulated in 1979, included practices such as flying only 737 aircraft, maintaining 10-minute gate turns, and offering no food service. Only about 20 percent of these elements changed over 25 years. The 10X companies altered their recipe ingredients an average of only 15 percent during their study eras, compared to 60 percent for comparisons. PSA, despite having invented the recipe Southwest later adopted, abandoned it after deregulation and eventually lost its independence. Intel's exit from memory chips in 1985 illustrates how to amend a recipe: The company changed one critical element while keeping the rest intact, including Moore's Law (the principle of doubling circuit complexity every 18 months to two years), manufacturing standardization, and sustained research and development investment through recessions.

The authors devote their final analytical chapter to luck. After coding 230 luck events, they find that 10X cases averaged seven significant good-luck events versus eight for comparisons. The 10X companies were not generally luckier. The critical differentiator is what the authors call Return on Luck (ROL): What you do with the luck you get. Progressive Insurance CEO Lewis illustrates high ROL on bad luck: When California's Proposition 103 mandated 20 percent insurance price cuts in 1988, Lewis used the crisis to create rapid claims service, climbing from 13th to fourth in the auto-insurance market. The authors identify an asymmetry: A single stroke of good luck cannot make a great company, but a single stroke of catastrophic bad luck can end the quest permanently.

The book concludes that greatness is primarily a matter of conscious choice and discipline, not circumstance. The authors reject the notion of a "New Normal," arguing that instability is chronic and uncertainty permanent, and that stable prosperity in developed economies during the second half of the 20th century was a historical aberration. Drawing on more than 6,000 years of combined corporate history across all their research, they assert that people are not imprisoned by their circumstances but are free to become great by choice.